Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

United Therapeutics Corporation (UTHR)

-NasdaqGS
96.20 Down 2.02(2.06%) Apr 17, 4:00PM EDT
|After Hours : 98.22 Up 2.02 (2.10%) Apr 17, 4:59PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 289,017   302,225   280,606   245,136  
Cost of Revenue38,778  30,716  32,320  29,313  
Gross Profit 250,239   271,509   248,286   215,823  
Operating Expenses
Research Development121,552  72,749  54,617  50,430  
Selling General and Administrative157,178  94,111  71,365  71,356  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (28,491) 104,649   122,304   94,037  
Income from Continuing Operations
Total Other Income/Expenses Net1,423  951  807  1,281  
Earnings Before Interest And Taxes(27,068)105,719  123,039  95,271  
Interest Expense4,562  4,540  4,520  4,436  
Income Before Tax(31,630)101,179  118,519  90,835  
Income Tax Expense(1,316)38,494  38,655  28,510  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(30,314)62,804  79,792  62,278  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (30,314) 62,685   79,864   62,325  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (30,314) 62,685   79,864   62,325  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.